X0306 4 2018-09-09 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001726096 Daniell Richard C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 BASEL STREET PETACH TIKVA L3 4951033 ISRAEL 0 1 0 0 Exec. VP, European Commercial Ordinary Shares 2018-09-09 4 M 0 696 A 696 D Ordinary Shares 2018-09-10 4 S 0 696 21.2502 D 0 D Restricted Share Units 2018-09-09 4 M 0 696 0.00 D Ordinary Shares 696 1394 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.2500 to $21.2515, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Restricted share units were granted on September 9, 2016, with 696 vesting on each of September 9, 2018 and September 9, 2019 and 698 vesting on September 9, 2020. /s/ Dov Bergwerk, as attorney-in-fact for Richard Daniell 2018-09-11